Clinical Trial

Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis

Study acronym: VASCO
Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to follow a cohort of osteoporotic patients treated with anti-osteoporotic drugs and to evaluate the impact of these treatments on the osteoporosis-cardiovascular-sarcopenia triad and on pain.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-01-27.
Status change: Not Yet Recruiting → Recruiting 2022-10-06
Trial Details
NCT Number NCT05228262
Lead Sponsor University Hospital, Clermont-Ferrand
Conditions Osteoporosis, Postmenopausal
Enrollment 150 participants
Start Date 2022-02-15
Primary Completion 2027-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2022-10-10